Molecular Testing in Metastatic Gastric/GEJ Cancer
3 Bekeken
• 06/30/23
0
0
insluiten
administrator
abonnees
David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties